Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Carcinoma in Situ

Known as: in situ carcinoma, Carcinoma in Situ [Disease/Finding], Non-invasive Carcinoma 
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without… Expand
National Institutes of Health

Related topics

Related topics

50 relations
Blood supply aspectsCDISC SEND Tumor Findings Results TerminologyCarcinoma in situ of bladderCarcinoma in situ of esophagus
Expand

Narrower (5)

Carcinoma in situ of penisCarcinoma in situ of skinEncapsulated papillary carcinomaStage 0 Pharynx Carcinoma
Expand

Broader (2)

In situ cancerIntraepithelial Neoplasia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Ductal carcinoma in situ, complexities and challenges.
The incidence of ductal carcinoma in situ (DCIS), a noninvasive form of breast cancer, has increased markedly in recent decades… Expand
Highly Cited
2003
Highly Cited
2003
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials.
BACKGROUND The effects of dietary fats on the risk of coronary artery disease (CAD) have traditionally been estimated from their… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2002
Highly Cited
2002
Detection of ductal carcinoma in situ in women undergoing screening mammography.
BACKGROUND With the large number of women having mammography-an estimated 28.4 million U.S. women aged 40 years and older in 1998… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
2001
Highly Cited
2001
Engineering of efficient panchromatic sensitizers for nanocrystalline TiO(2)-based solar cells.
A new series of panchromatic ruthenium(II) sensitizers derived from carboxylated terpyridyl complexes of tris-thiocyanato Ru(II… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
2000
Highly Cited
2000
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
PURPOSE Bacillus Calmette-Guerin (BCG) immunotherapy has been widely accepted as the optimal treatment for carcinoma in situ and… Expand
Review
2000
Review
2000
The Vienna classification of gastrointestinal epithelial neoplasia
BACKGROUND Use of the conventional Western and Japanese classification systems of gastrointestinal epithelial neoplasia results… Expand
Highly Cited
1999
Highly Cited
1999
The influence of margin width on local control of ductal carcinoma in situ of the breast.
BACKGROUND Ductal carcinoma in situ is a non-invasive carcinoma that is unlikely to recur if completely excised. Margin width… Expand
Highly Cited
1996
Highly Cited
1996
A prognostic index for ductal carcinoma in situ of the breast
There is controversy and confusion regarding therapy for patients with ductal carcinoma in situ (DCIS) of the breast. The Van… Expand
Review
1994
Review
1994
Ductal carcinoma in situ: a proposal for a new classification.
Details of a proposed new classification for ductal carcinoma in situ (DCIS) are presented. This is based, primarily, on… Expand
Highly Cited
1989
Highly Cited
1989
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
The enzyme peptidyl-prolyl cis-trans isomerase (PPIase) was recently discovered in mammalian tissues and purified from porcine… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE